Unraveling MASLD: Pathways, Risks, and Treatment Strategies

In this episode, we dive deep into the complexities of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). With its rising global prevalence, MASLD is linked to serious health risks, including type 2 diabetes and cardiovascular disease. Join us as we explore the heterogeneous nature of its pathogenesis, the effectiveness of metabolism-based treatments, and the challenges of balancing pharmacological options that may lead to weight gain. Together, we'll discuss actionable solutions to combat this escalating epidemic and improve liver health.